E picardial mapping and ablation via subxiphoid percutaneous ablation has advanced the field of ventricular tachycardia ablation in the setting of structural heart disease. Significant pericardial adhesions are well recognized in the setting of post cardiac surgery and recurrent pericarditis. We present a rare complication that resulted during dissection of pericardial adhesions during a percutaneous approach in a patient without prior history of cardiac surgery or pericarditis.
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Case Presentation
A sixty-seven-year-old woman presented with a history of palpitations and presyncope over a 2 month period. During hospitalization, she had an episode of paroxysmal ventricular tachycardia with right bundle branch block morphology and R wave-dominant precordium (Figure 1 ). Ejection fraction was 70% without wall motion abnormalities. She did not have a history of myocardial infarction, myocarditis, or tuberculosis. She underwent an endocardial ablation, which was unsuccessful, and no low-voltage or abnormal substrate was identified.
She underwent a second procedure with planned percutaneous subxiphoid approach for epicardial access. On a posterior puncture of the pericardium with a 17G Tuohy needle under fluoroscopic guidance, dense adhesions were encountered ( Figure 2 ). A 5F dilator was advanced over the limited wire entry to confirm adhesions in the pericardial space. Gradual adhesiolysis was achieved with passage of a long wire and off-label usage of a steerable sheath (Agilis; St Jude Medical, Minneapolis, MN) to direct a duodecapolar mapping catheter (Livewire; St Jude Medical). No bleeding was observed with sheath aspiration.
After 45 minutes of epicardial mapping, ST elevations in leads I and aVL with global depressions were suddenly observed. Aspiration of the sheath revealed bloody drainage, and contrast injected into the pericardium confirmed a moderate effusion with inferolateral accumulation. After surgical consultation was emergently requested, continuous aspiration under suction was performed for an hour, with a total output of 800 ml. Coronary angiography revealed slow flow in the circumflex and obtuse marginal branch without contrast extravasation ( Figure 2 ). Because of continued bleeding, the patient was taken for exploratory sternotomy. A subepicardial dissection with hematoma was seen in the inferolateral wall, with unroofing of the circumflex artery from the midmyocardium. (Figure 3 ; Movie in the Data Supplement) There was no overt bleeding from the circumflex artery, and the epicardial dissection flap was stitched back to the myocardium and repaired. Bleeding ceased and the patient was discharged 3 days with an uneventful postoperative course.
Discussion
To the best of our knowledge, this is the first report of this rare complication that occurred during blind catheter-assisted dissection of pericardial adhesions. While many centers opt for a primary surgical approach to release adhesions, recent reports have demonstrated feasibility and safety of the percutaneous approach in the setting of prior cardiac surgery, including coronary artery bypass graft. 1, 2 In these published experiences, adhesiolysis is always necessary, and exposure of the entire epicardial surface remains incomplete. In this case, we speculate that the substrate for ventricular tachycardia and pericardial adhesions was postinflammatory from a myo-pericariditis because it is uncommon to encounter adhesions without a history of prior instrumentation. Although more invasive, hybrid approaches with surgical access may improve safety because direct visualization and manual manipulation is immediately available. 3,4
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